(Q33705523)

28 July 2017

1 reference

title

Pulmonary diseases other than asthma as potential targets for antileukotriene therapy (English)

1 reference

28 July 2017

1 reference

Peters-Golden M

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

Clinical Reviews in Allergy & Immunology

28 July 2017

published in

1 reference

28 July 2017

volume

17

1 reference

28 July 2017

issue

1-2

1 reference

28 July 2017

page(s)

247-260

1 reference

Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Neutrophil Chemotactic Factors in the Respiratory Tract of Patients with Chronic Airway Diseases or Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Leukotrienes in the sputum and urine of cystic fibrosis children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

The formation of thromboxane B2, leukotriene B4 and 12-hydroxyeicosatetraenoic acid by alveolar macrophages after activation during tumor growth in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737608

Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia.

21 January 2018

1 reference

12 December 2020

Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production

1 reference

12 December 2020

Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease

1 reference

12 December 2020

Increased plasma levels of atrial natriuretic factor, renin activity, and leukotriene C4 in chronic obstructive pulmonary disease

1 reference

12 December 2020

Detection of leukotrienes B4, C4 and of their isomers in arterial, mixed venous blood and bronchoalveolar lavage fluid from ARDS patients

1 reference

12 December 2020

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats

1 reference

12 December 2020

A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model

1 reference

12 December 2020

[Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]

1 reference

12 December 2020

Lipid mediators in oxygen-induced airway remodeling and hyperresponsiveness in newborn rats

1 reference

12 December 2020

Eicosapentaenoic acid in cystic fibrosis: evidence of a pathogenetic role for leukotriene B4

1 reference

12 December 2020

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

1 reference

12 December 2020

Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome

1 reference

12 December 2020

Sputum leukotrienes in obstructive airways diseases

1 reference

12 December 2020

Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus

1 reference

12 December 2020

Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema

1 reference

12 December 2020

Acute lung injury in endotoxemic pigs: role of leukotriene B4

1 reference

12 December 2020

Sputum cysteinyl‐leukotriene levels correlate with the severity of pulmonary disease in children with cystic fibrosis

1 reference

12 December 2020

Leukotriene generation in patients with multiple injuries

1 reference

12 December 2020

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

12 December 2020

Colchicine Versus Prednisone as Treatment of Usual Interstitial Pneumonia

1 reference

12 December 2020

Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep

1 reference

12 December 2020

Variations in chemical mediators of hypersensitivity in the sputum of chronic bronchitics: correlation with peak expiratory flow

1 reference

12 December 2020

Diethylcarbamazine inhibits acute and chronic hypoxic pulmonary hypertension in awake rats.

1 reference

12 December 2020

LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs

1 reference

12 December 2020

Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis

1 reference

12 December 2020

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

1 reference

12 December 2020

Arachidonic acid metabolism is altered in sarcoid alveolar macrophages.

1 reference

12 December 2020

Colchicine inhibits arachidonate release and 5-lipoxygenase action in alveolar macrophages.

1 reference

12 December 2020

A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus

1 reference

12 December 2020

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis

1 reference

12 December 2020

Leukotriene B4 in Bronchoalveolar Lavage Fluid of Patients With Diffuse Panbronchiolitis

1 reference

12 December 2020

gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters

1 reference

12 December 2020

Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS

1 reference

12 December 2020

Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage

1 reference

12 December 2020

Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease

1 reference

12 December 2020

Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis

1 reference

12 December 2020

Leukotrienes and alpha tumor necrosis factor levels in the bronchoalveolar lavage fluid of patient at risk for the adult respiratory distress syndrome

1 reference

12 December 2020

Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension.

1 reference

12 December 2020

The role of leukotriene B4 in the genesis of oxygen toxicity in the lung

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02737608

1 reference

Dimensions Publication ID

28 July 2017

1012978231

0 references

1 reference